Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Kirshma Khemani, Staci D. Arnold, Nitya Bakshi, Diana Ross, Crystal Smith, Anirban Basu, Elizabeth Stenger, Lakshmanan Krishnamurti

Blood (2022) 140 (Supplement 1): 13043–13044.

https://doi.org/10.1182/blood-2022-170685

Published: 2022

Journal Articles

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

Staci D. Arnold, Nitya Bakshi, Zhao Chang, Diana Ross, Allistair Abraham, Monica Bhatia, Gregory M.T. Guilcher, Ann Haight, Matthew Hsieh, Kimberly A. Kasow, Peter A. Lane, Lillian Meacham, Festus Olusola Olowoselu, Lakshmanan Krishnamurti

Blood (2021) 138 (Supplement 1): 425.

https://doi.org/10.1182/blood-2021-154280

Published: 2021

Journal Articles

The Influence of the Age of Adults with Sickle Cell Disease on the Uptake, Utilization and Efficacy of Hydroxyurea

Cynthia Sinha, PhD, Nitya Bakshi, MBBS, MS, Diana Ross, MSN, RN, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 3421.

https://doi.org/10.1182/blood.V130.Suppl_1.3421.3421

Published: 2017

Journal Articles

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Elizabeth Stenger, MD, Kirshma Khemani, MD, Diana Ross, MSN, RN, Lillian Meacham, MD, Courtney McCracken, PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 1999.

https://doi.org/10.1182/blood.V130.Suppl_1.1999.1999

Published: 2017

Journal Articles

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Nitya Bakshi, MBBS, MS, Cynthia Sinha, PhD, Diana Ross, MSN, RN, Kirshma Khemani, MD, George Loewenstein, PhD, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 4757.

https://doi.org/10.1182/blood.V128.22.4757.4757

Published: 2016

Journal Articles

Development, Implementation, and Testing of a Web Based Decision Aid for Facilitating Shared Decision Making for Disease Modifying Therapies for Sickle Cell Disease

Lakshmanan Krishnamurti, MD, Diana Ross, MSN, RN, Nitya Bakshi, MBBS, MS, Kirshma Khemani, MD, Cynthia Sinha, PhD, George Loewenstein, PhD

Blood (2016) 128 (22): 5919.

https://doi.org/10.1182/blood.V128.22.5919.5919

Published: 2016

Journal Articles

What Are the Expectations of Patients in Decision Making Process for Disease Modifying Therapies for Sickle Cell Disease: Do They Care about Shared Decision Making?

Diana Ross, MSN, RN, Nitya Bakshi, MBBS, MS, Kirshma Khemani, MD, Cynthia Sinha, PhD, George Loewenstein, PhD, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 5968.

https://doi.org/10.1182/blood.V128.22.5968.5968

Published: 2016

Journal Articles

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Kirshma Khemani, MD, Diana Ross, MSN, RN, Ann Haight, MD, Cynthia Sinha, PhD, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 2393.

https://doi.org/10.1182/blood.V128.22.2393.2393

Published: 2016

Journal Articles

Development, Establishment Of the Psychometric Properties and Usability Testing Of a Novel Multi-Dimensional Web Based Diary For Children With Sickle Cell Disease

Nitya Bakshi, MBBS, Jennifer Stinson, RN, PhD, CPNP, Ines Lukombo, Diana Ross, MSN, RN, Nonita Mittal, MBBS, Saumya Vinod Joshi, MBBS, Lakshmanan Krishnamurti, MD

Blood (2013) 122 (21): 2961.

https://doi.org/10.1182/blood.V122.21.2961.2961

Published: 2013

NARROW

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

The Influence of the Age of Adults with Sickle Cell Disease on the Uptake, Utilization and Efficacy of Hydroxyurea

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Development, Implementation, and Testing of a Web Based Decision Aid for Facilitating Shared Decision Making for Disease Modifying Therapies for Sickle Cell Disease

What Are the Expectations of Patients in Decision Making Process for Disease Modifying Therapies for Sickle Cell Disease: Do They Care about Shared Decision Making?

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Development, Establishment Of the Psychometric Properties and Usability Testing Of a Novel Multi-Dimensional Web Based Diary For Children With Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only